Venrock
Venrock is a US venture capital firm (founded 1969, Palo Alto) operating two programs — an early-stage tech and healthcare venture program and a later-stage Crossover/Public Healthcare program (VHCP) — investing across Seed through Series B+ and managing 100+ portfolio companies.
- Company typePrivate
- Founded1978
- HeadquartersPalo Alto, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Venrock does
Venrock is a US-based venture capital firm founded in 1969, headquartered in Palo Alto, California, with additional offices in New York and Boston. It operates two distinct investment programs: a traditional early-stage venture capital program investing in technology and healthcare companies from Seed through Series B+, and a separate later-stage program called Venrock Healthcare Capital Partners (VHCP), operated at venrockcp.com, which applies a venture-style long-duration approach to small-cap public and late-stage private healthcare companies. The firm invests in sectors including AI/ML, SaaS, FinTech, Consumer, Developer Infrastructure, Cybersecurity, Defense & Aerospace, Biotechnology, Pharmaceuticals, Life Science Tools, and Health Tech, with a portfolio exceeding 100 companies and notable alumni such as Apple (since 1978), Intel, Illumina, Cloudflare, 10X Genomics, athenahealth, Lucid Motors, REGENXBIO, and Gilead Sciences.
The firm does not develop proprietary technology products; its operational infrastructure consists of investment management systems, an eFront LP portal, a corporate website with a Companies showcase, the Running Through Walls podcast, an AI Strategy content hub, and newsletter distribution. It is staffed by approximately 50+ team members across Investment Team, Portfolio Advisory Committee, Finance, Legal/Compliance, Marketing, Talent, IT, and Support functions. The investment team includes domain-specialized Partners in SaaS/Enterprise & AI (Brian Ascher), AI/Compute/Defense (Ethan Batraski, Nick Beim), Biotechnology/Pharma (Racquel Bracken, Phil DiGiacomo, Mariana Mihalusova), Health Tech (Bob Kocher, Bryan Roberts, Siobhan Nolan Mangini), and Enterprise/Mobile (Mike Tyrrell, Boston), with a separate VHCP team and an external Portfolio Advisory Committee.
Venrock's revenue model is conventional for venture capital: it earns capital appreciation and exit proceeds (IPOs and M&A) on portfolio holdings, supplemented by management fees on funds it manages. The firm does not publicly disclose management fees, carried interest, or fund economics, and its website explicitly states that materials are not offers or solicitations. Deal flow is sourced primarily through proprietary partner networks, direct founder outreach, and syndicate relationships with co-investors such as Bain Capital Ventures, Battery Ventures, Highland Europe, Insight, Meritech, and Frazier Life Sciences.
Venrock firmographics
Firmographics- Name
- Venrock
- Legal name
- Venrock Associates
- Website
- https://venrock.com
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Venrock is a US venture capital firm (founded 1969, Palo Alto) operating two programs — an early-stage tech and healthcare venture program and a later-stage Crossover/Public Healthcare program (VHCP) — investing across Seed through Series B+ and managing 100+ portfolio companies.
- Ownership category
- akta.pro rank
Venrock industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Venture Capital (CVC) (FSANAAAF)
- akta.pro secondary industry
- Joint Venture CVC / Consortium Funds (Multi-corporate) (FSANAHAE)
Keywords
Where Venrock is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Venrock business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Venture capital fund investments: Operates two investment programs: an early-stage venture capital program focused on healthcare and technology, and a later-stage Crossover/Public Healthcare program (VHCP) for small-cap public and late-stage private healthcare companies. Returns are generated via capital appreciation and exits (IPOs and M&A) on portfolio holdings; the firm does not publicly disclose management fees or carried interest terms.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Venrock product offering
Product offeringCore offering
Venrock is a private venture capital firm that deploys risk capital into early-stage technology and healthcare companies from Seed through Series B+ stages. It operates two distinct investment programs: a traditional early-stage venture capital program spanning AI/ML, SaaS, FinTech, Consumer, Developer Infrastructure, Therapeutics, Health Tech, Life Science Tools, and Medical Devices, and a separate later-stage Crossover/Public Healthcare program (VHCP) that applies a venture-style long-term approach to small-cap public and late-stage private healthcare companies.
Product overview
Venrock is a venture capital firm — not a software product company — and its "offerings" are organized as two distinct investment programs plus a small set of content/media properties. The primary offering is the traditional Venture Capital Program, which makes early-stage investments across healthcare and technology (with sub-sectors including AI, FinTech, Consumer, Developer Infrastructure, Therapeutics, Health Tech, Life Science Tools, and Medical Devices), supporting portfolio companies such as Archetype AI, Astronomer, Altruist, 6sense, Dataminr, Cloudflare, Apple, and Intel. The second offering is Venrock Healthcare Capital Partners (VHCP), a separate later-stage healthcare program (operating at venrockcp.com) that applies a venture capital-like long-term approach to small-cap public and late-stage private healthcare companies. In addition to these two investment programs, Venrock publishes thought-leadership content including the "Running Through Walls" podcast and an AI Strategy content hub on venrock.com, which together complement the firm's investment activities with brand-building and founder/enterprise education.
Differentiator
Problem solved
Functional benefit
Brands
- Venrock Crossover / Public Healthcare (VHCP): Later-stage healthcare investment program operated through venrockcp.com, focused on small-capitalization public companies and late-stage private healthcare companies using a venture capital-like long-term approach.
Products and services
- Traditional Venture Capital Program Early-stage venture capital program investing in healthcare and technology companies across AI/ML, SaaS, FinTech, Consumer, Developer Infrastructure, Therapeutics, Health Tech, Life Science Tools, and Medical Devices. Capital is provided at Seed, Series A, and Series B+ stages to founders building technology and healthcare companies.
- Venrock Healthcare Capital Partners (VHCP / Crossover/Public Healthcare Program) Later-stage healthcare investment program that applies a venture capital-like long-term approach to small-capitalization public healthcare companies and late-stage private healthcare companies. Operates through a dedicated website (venrockcp.com) and is staffed by a distinct VHCP team.
Quantifiable outcome
- Apple investment since 1978 grew into one of the world's largest publicly traded companies (NASDAQ: AAPL).
- +5 more outcomes
Companies that use Venrock
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles3 records
Venrock technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Venrock partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights7 records
Venrock competitors and assessment
Company assessmentDirect peers
- Andreessen Horowitz (a16z): US-based venture capital firm investing across technology and healthcare stages with a multi-fund, multi-strategy structure similar to Venrock's two-program approach. a16z operates Bio + Health and general tech funds that directly compete with Venrock for the same founder-led deal flow in AI, biotech, and FinTech.
- Sequoia Capital: Palo Alto-based early- and growth-stage venture capital firm with deep healthcare and technology franchises, including the well-known Apple investment lineage that parallels Venrock's heritage. Sequoia competes with Venrock across seed, Series A, and later stages in software, biotech, and healthcare technology.
- New Enterprise Associates (NEA): Large, multi-stage US venture capital firm with healthcare and technology practices operating across seed through growth stages. NEA's healthcare franchise and size are closely comparable to Venrock's combined early-stage and VHCP capabilities.
- Kleiner Perkins: Silicon Valley-based venture capital firm with parallel technology and healthcare/life sciences franchises, including legendary early investments in companies like Genentech and Google. Kleiner Perkins competes with Venrock for Bay Area AI, biotech, and health tech deals.
- Bessemer Venture Partners: Multi-stage US venture capital firm with a long healthcare and technology track record, including notable public-company alumni comparable to Venrock's. BVP's cross-stage approach and biotech/cloud investing focus overlap directly with Venrock's programs.
- ARCH Venture Partners: US venture capital firm focused on early-stage biotechnology, life sciences, and physical sciences, with comparable scale and stage to Venrock's healthcare practice. ARCH competes with Venrock Healthcare Capital Partners for founder-led biotech seed and Series A opportunities.
- OrbiMed Advisors: Healthcare-dedicated investment firm spanning venture, growth, and public equities, paralleling Venrock's combination of early-stage biotech investing and VHCP crossover capabilities. OrbiMed is a frequent co-investor and direct competitor in life sciences financings.
- RA Capital Management: Boston-based crossover fund focused on healthcare and biotech with both public-equity and late-stage private investing, structurally similar to Venrock's VHCP program. RA Capital appears in multiple recent syndicates alongside Venrock (cAMPfield, Adcendo) and competes for the same crossover opportunities.
- GV (Google Ventures): US venture capital arm of Alphabet investing across technology and life sciences at seed through growth stages. GV competes with Venrock in AI, biotech, and healthcare technology with comparable US footprint (Mountain View, Boston, London, New York).
- Frazier Life Sciences: Healthcare-focused venture capital firm investing across biotech and therapeutics at seed through public stages. Frazier led cAMPfield's $180M Series A that Venrock participated in and is a direct competitor in life sciences deal flow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Venrock social profiles
Digital presenceVenrock financial estimates
Financial estimateRevenue estimate
Valuation estimate
Venrock leadership team
Management profileNumber of profiles
Profiles20 records
Venrock subsidiaries and ownership
Company hierarchySubsidiaries1 record
Venrock funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Venrock M&A and investment
M&A and investmentM&A
Investments912 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Venrock
What does Venrock do?
Venrock is a private venture capital firm that deploys risk capital into early-stage technology and healthcare companies from Seed through Series B+ stages. It operates two distinct investment programs: a traditional early-stage venture capital program spanning AI/ML, SaaS, FinTech, Consumer, Developer Infrastructure, Therapeutics, Health Tech, Life Science Tools, and Medical Devices, and a separate later-stage Crossover/Public Healthcare program (VHCP) that applies a venture-style long-term approach to small-cap public and late-stage private healthcare companies.
Is Venrock a public or private company?
Venrock is a private company. It is classified as management employee owned and is currently operating.
When was Venrock founded?
Venrock was founded in 1978. It employs 101 to 250 people.
Where is Venrock based?
Venrock is headquartered in Palo Alto, United States, in the North America region.
How does Venrock make money?
One revenue line is on record: venture capital fund investments.
Who are Venrock's main competitors?
Direct peers on record are Andreessen Horowitz (a16z), Sequoia Capital, New Enterprise Associates (NEA), Kleiner Perkins, Bessemer Venture Partners, ARCH Venture Partners, OrbiMed Advisors, RA Capital Management, GV (Google Ventures) and Frazier Life Sciences.
Does Venrock have an API?
No public API is recorded for Venrock.
What industry is Venrock in?
Venrock's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAF, Corporate Venture Capital (CVC), with a secondary code of FSANAHAE, Joint Venture CVC / Consortium Funds (Multi-corporate). Its NAICS code is 523940 and its SIC code is 6282.